Free Trial

Trellus Health (TRLS) Competitors

GBX 0.64 -0.01 (-2.00%)
As of 08/5/2025 11:07 AM Eastern

TRLS vs. IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, RENX, COG, and INHC

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), Renalytix (RENX), Cambridge Cognition (COG), and Induction Healthcare Group (INHC). These companies are all part of the "health information services" industry.

Trellus Health vs. Its Competitors

Trellus Health (LON:TRLS) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, earnings, analyst recommendations, institutional ownership, risk and valuation.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
IQ-AI Neutral

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£65.83K18.71-£7.98M-£3.45-0.18
IQ-AI£538.19K3.30N/AN/AN/A

19.3% of Trellus Health shares are owned by institutional investors. 49.7% of Trellus Health shares are owned by company insiders. Comparatively, 66.0% of IQ-AI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-12,114.55% -37.95% -22.76%
IQ-AI -77.52%-140.75%-22.03%

Trellus Health has a beta of 0.01, suggesting that its share price is 99% less volatile than the S&P 500. Comparatively, IQ-AI has a beta of 2.25, suggesting that its share price is 125% more volatile than the S&P 500.

Summary

IQ-AI beats Trellus Health on 5 of the 9 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£1.23M£227.67M£5.59B£3.06B
Dividend YieldN/A5.90%4.73%5.02%
P/E Ratio-0.18383.8528.91169.43
Price / Sales18.71222.58445.59327,336.00
Price / Cash0.7647.1435.6827.97
Price / Book0.075.178.164.54
Net Income-£7.98M-£15.55M£3.25B£5.90B
7 Day Performance0.47%0.52%1.17%0.91%
1 Month Performance-2.00%2.85%8.27%11.86%
1 Year Performance-51.92%9.88%29.19%71.66%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.64
-2.0%
N/A-52.1%£1.23M£65.83K-0.1831Gap Down
IQAI
IQ-AI
N/AGBX 0.80
flat
N/A-33.3%£1.77M£538.19K-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.2298 of 5 stars
GBX 2,371.67
+1.4%
GBX 2,725
+14.9%
+6.2%£1.02B£230.77M87.62734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
2.2301 of 5 stars
GBX 181
-3.2%
GBX 456.67
+152.3%
-49.3%£66.43M£50.72M17.01478
RENX
Renalytix
N/AGBX 7.13
-1.7%
N/A-45.7%£29.54M£9.22M-0.34102Gap Down
COG
Cambridge Cognition
N/AGBX 31.50
-3.1%
N/A-40.5%£13.19M£15.64M-8.3780Gap Down
INHC
Induction Healthcare Group
N/AGBX 9.75
flat
N/A-2.5%£9.00M£12.57M-1.7674

Related Companies and Tools


This page (LON:TRLS) was last updated on 8/6/2025 by MarketBeat.com Staff
From Our Partners